We used different concentration of cisplatin (0.1, 0.5, 2.5, 5, and 10 μg/mL) to treat gastric cancer cells with Rab11a overexpression and depletion and checked the inhibition rate of cisplatin on cell viability using MTT assays. The gene discussed is RAB11A; the disease is gastric cancer.